Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of MedImmune patents

Patents where

Current Assignee

Name

MedImmune

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7229619 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment	Patent 7229619 was granted and assigned to MedImmune on June, 2007 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7229619	June 12, 2007
‌ US Patent 7179900 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment	Patent 7179900 was granted and assigned to MedImmune on February, 2007 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7179900	February 20, 2007
‌ US Patent 7323172 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment	Patent 7323172 was granted and assigned to MedImmune on January, 2008 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7323172	January 29, 2008
‌ US Patent 10457724 Methods of treating	Patent 10457724 was granted and assigned to MedImmune on October, 2019 by the United States Patent and Trademark Office.	MedImmune	MedImmune	United States Patent and Trademark Office	10457724	October 29, 2019
‌ US Patent 7585504 High affinity antibodies against HMGB1 and methods of use thereof	Patent 7585504 was granted and assigned to MedImmune on September, 2009 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7585504	September 8, 2009
‌ US Patent 9957312 B7-H4 fusion proteins and methods of use thereof	Patent 9957312 was granted and assigned to MedImmune on May, 2018 by the United States Patent and Trademark Office.	MedImmune, LLC	MedImmune	United States Patent and Trademark Office	9957312	May 1, 2018
‌ US Patent 9845348 Methods of treating	Patent 9845348 was granted and assigned to MedImmune on December, 2017 by the United States Patent and Trademark Office.	MedImmune	MedImmune	United States Patent and Trademark Office	9845348	December 19, 2017
‌ US Patent 10457732 Bispecific binding proteins and uses thereof	Patent 10457732 was granted and assigned to MedImmune on October, 2019 by the United States Patent and Trademark Office.	MedImmune	MedImmune	United States Patent and Trademark Office	10457732	October 29, 2019
‌ US Patent 9879067 Stabilized liquid anti-RSV antibody formulations	Patent 9879067 was granted and assigned to MedImmune on January, 2018 by the United States Patent and Trademark Office.	MedImmune	MedImmune	United States Patent and Trademark Office	9879067	January 30, 2018
‌ US Patent 8481037 Recombinant IL-9 antibodies and uses thereof	Patent 8481037 was granted and assigned to MedImmune on July, 2013 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	8481037	July 9, 2013
‌ US Patent 7700735 High potency recombinant antibodies and method for producing them	Patent 7700735 was granted and assigned to MedImmune on April, 2010 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7700735	April 20, 2010
‌ US Patent 11482315 Device accessory for digitally monitoring autoinjector usage for improved compliance, remote patient monitoring, and adherence		MedImmune	MedImmune	United States Patent and Trademark Office	11482315	October 25, 2022
‌ US Patent 7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations	Patent 7425618 was granted and assigned to MedImmune on September, 2008 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7425618	September 16, 2008
‌ US Patent 7083784 Molecules with extended half-lives, compositions and uses thereof	Patent 7083784 was granted and assigned to MedImmune on August, 2006 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7083784	August 1, 2006
‌ US Patent 7670837 Non-tumorigenic MDCK cell line for propagating viruses	Patent 7670837 was granted and assigned to MedImmune on March, 2010 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7670837	March 2, 2010
‌ US Patent 7132100 Stabilized liquid anti-RSV antibody formulations	Patent 7132100 was granted and assigned to MedImmune on November, 2006 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7132100	November 7, 2006
‌ US Patent 7294336 Stabilized liquid anti-RSV antibody formulations	Patent 7294336 was granted and assigned to MedImmune on November, 2007 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7294336	November 13, 2007
‌ US Patent 7354584 Recombinant IL-9 antibodies	Patent 7354584 was granted and assigned to MedImmune on April, 2008 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7354584	April 8, 2008
‌ US Patent 7608260 Stabilized immunoglobulins	Patent 7608260 was granted and assigned to MedImmune on October, 2009 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	7608260	October 27, 2009
‌ US Patent 11608375 Binding molecules specific for ASCT2 and uses thereof	Patent 11608375 was granted and assigned to MedImmune on March, 2023 by the United States Patent and Trademark Office.	MedImmune	MedImmune	United States Patent and Trademark Office	11608375	March 21, 2023
‌ US Patent 10016496 Respiratory syncytial virus F protein epitopes	Patent 10016496 was granted and assigned to MedImmune on July, 2018 by the United States Patent and Trademark Office.	MedImmune	MedImmune	United States Patent and Trademark Office	10016496	July 10, 2018
‌ US Patent 8093033 Multi plasmid system for the production of influenza virus	Patent 8093033 was granted and assigned to MedImmune on January, 2012 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	8093033	January 10, 2012
‌ US Patent 8008443 Modulation of antibody effector function by hinge domain engineering	Patent 8008443 was granted and assigned to MedImmune on August, 2011 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	8008443	August 30, 2011
‌ US Patent 8409843 Multi plasmids system for the production of influenza virus	Patent 8409843 was granted and assigned to MedImmune on April, 2013 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	8409843	April 2, 2013
‌ US Patent 8119388 Non-tumorigenic MDCK cell line for propagating viruses	Patent 8119388 was granted and assigned to MedImmune on February, 2012 by the United States Patent and Trademark Office.		MedImmune	United States Patent and Trademark Office	8119388	February 21, 2012

...

Results per page:

206 results

0 selected

206 results

0 selected